This is demonstrated by the elevated expression levels of Nrf2, HO-1, and NQO1 observed in our in vivo PD model treated with Omaveloxolone, indicating its protective role against neurodegeneration induced by oxidative stress. Here, NQO1 is linked to Parkinson disease.